ONO-LB 457

Known as: ONO-LB-457 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2013
012319992013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Novokinin (RPLKPW) was designed based on ovokinin (FRADHPFL), a vasorelaxing peptide derived from ovalbumin. Novokinin relaxed a… (More)
Is this relevant?
2010
2010
The effects of prostaglandin E(2) (PGE(2)) on platelet function are believed to be the result of opposing mechanisms that lead to… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
BACKGROUND AND PURPOSE Although microsomal prostaglandin E synthase (mPGES)-1 is known to contribute to stroke injury, the… (More)
Is this relevant?
2009
2009
Novokinin (Arg-Pro-Leu-Lys-Pro-Trp), having affinity for the AT(2) receptor, is a potent vasorelaxing and hypotensive peptide… (More)
Is this relevant?
2009
2009
Prostaglandin E2 (PGE2) can stimulate tumor progression by both direct and indirect mechanisms. However, its influence on cell… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
BACKGROUND Prostaglandin (PG) E(2) exerts a variety of actions through 4 G protein-coupled receptors designated as EP(1), EP(2… (More)
Is this relevant?
2007
2007
Prostaglandin (PG)E(2) has been shown to inhibit mediator release from human alveolar macrophages (AMs), but the prostanoid… (More)
Is this relevant?
2006
2006
Prostaglandin E(2) (PGE(2)), one of the major metabolites of cyclooxygenase-2, has been implicated in tumorigenesis and tumor… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
Prostaglandin E2 (PGE2) is thought to be a principal fever mediator. There are four subtypes of PGE (EP) receptors, EP1-EP4. We… (More)
Is this relevant?
2000
2000
An increase of intracellular cAMP mediated by prostaglandin E2 (PGE2) has been shown to delay spontaneous apoptosis of… (More)
Is this relevant?